TIDMBHL
RNS Number : 1000O
Bradda Head Lithium Ltd
27 January 2023
27 January 2023
Bradda Head Lithium Ltd
("Bradda Head", "Bradda", or the "Company")
Unaudited Interim Results for the three and nine months ended 30
November 2022
Bradda Head Lithium Ltd (AIM: BHL), the North America-focused
lithium development group, is pleased to announce that it has today
published its unaudited financial results for the three and nine
months ended 30 November, 2022 and the Management's Discussion and
Analysis for the same period.
Both of the above have been posted on the Company's website
www.braddaheadltd.com and are also available on SEDAR at
www.sedar.com .
Financial and operational highlights for the third quarter
-- Commenced an updated Mineral Resource Estimate ("MRE") based
on a 1,200m sonic drill programme at Basin East ("BE"), with the
updated resource being announced post period end on January 16,
2023.
-- The updated MRE added 65 kt of LCE to the Mineral Resource,
for an updated total LCE content of 371 kt.
-- Drilling continued at the San Domingo pegmatite project, with
lithium-bearing minerals being identified in the first hole at this
programme, including spodumene and lepidolite.
-- Completed an initial soil sampling programme covering an
initial 3km (2) , identifying a potential >3km lithium-bearing
trend and highly-prospective follow-up drill targets.
-- Cash balances and total assets stood at US$ 10,603,037 and US$ 19,584,569 respectively.
-- On November 10, 2022, completed a dual listing on the TSX-Venture Exchange.
Ian Stalker, Chairman of Bradda Head, commented:
"The third quarter of the financial year has been very busy for
the Company. Drilling continued at our San Domingo pegmatite asset,
with lithium-bearing minerals being identified in the first drill
hole. Post quarter end, the Company also updated its Mineral
Resource Estimate at Basin East and highlighted the significant
exploration potential that remains within this large, mineralised
location. The pace of development will continue through the final
quarter and into the next financial year, and we look forward to
updating our shareholders as we receive the exploration
results."
The information contained within this announcement is deemed by
the Company to constitute inside information as stipulated under
the Market Abuse Regulations (EU) No. 596/2014 as it forms part of
UK domestic law by virtue of the European Union (Withdrawal) Act
2018 ("MAR"), and is disclosed in accordance with the Company's
obligations under Article 17 of MAR.
For further information please visit the Company's website:
www.braddaheadltd.com
For further information, please contact:
Bradda Head Lithium Limited +44 (0) 1624 639 396
Charlie FitzRoy, CEO
Denham Eke, Finance Director
Beaumont Cornish (Nomad)
James Biddle/Roland Cornish +44 20 7220 1666
Peterhouse (Joint Broker) +44 207 469 0930
Charles Goodfellow
Duncan Vasey
Lucy Williams
Shard Capital (Joint Broker) +44 207 186 9927
Damon Heath
Isabella Pierre
Red Cloud (North American Broker) +1 416 803 3562
Joe Fars
Tavistock (PR) + 44 20 7920 3150
Nick Elwes braddahead@tavistock.co.uk
Adam Baynes
About Bradda Head Lithium Ltd.
Bradda Head Lithium Ltd. is a North America-focused lithium
development group. The Company currently has interests in a variety
of projects, the most advanced of which are in Central and Western
Arizona: The Basin Project (Basin East Project, and the Basin West
Project) and the Wikieup Project.
The Basin East Project has an Indicated Mineral Resource of 21.2
Mt at an average grade of 891 ppm Li and 3.5% K for a total of 100
kt LCE and an Inferred Mineral Resource of 73.3 Mt at an average
grade of 694 ppm Li and 3.2% K for a total of 271 kt LCE. In the
rest of the Basin Project SRK has estimated an Exploration Target
of between 300 to 1,300 Mt of material grading between 600 to 850
ppm Li which is equivalent to a range of between 1 to 6 Mt LCE. The
Group intends to continue to develop its three phase one projects
in Arizona, whilst endeavouring to unlock value at its other
prospective pegmatite and brine assets in Arizona, Nevada, and
Pennsylvania. All of Bradda Head's licences are held on a 100%
equity basis and are in close proximity to the required
infrastructure. Bradda Head is quoted on the AIM of the London
Stock Exchange with the ticker of BHL, on the TSX Ventures exchange
with a ticker of BHLI, and on the US OTCQB market with a ticker of
BHLIF.
Management discussion and analysis for the three and nine-month
period ended November 30, 2022
This management's discussion and analysis ("MD&A") reports
on the operating results and financial condition of the Company for
the three and nine months ended November 30, 2022, and is prepared
as of January 27 ,2023. The MD&A should be read in conjunction
with Bradda Head Lithium Limited's (the "Company" or "Bradda Head")
unaudited consolidated financial statements for the three and nine
months ended November 30, 2022, and the audited annual consolidated
financial statement for the years ended February 28, 2022, and
February 28, 2021, and the notes thereto which were prepared in
accordance with International Financial Reporting Standards
("IFRS").
All dollar amounts referred to in this MD&A are expressed in
United States dollars except where indicated otherwise.
Overview
Bradda Head Lithium Limited was incorporated on October 28,
2009, in the British Virgin Islands under the British Virgin
Islands Companies Act with registered number 1553975 with the name
Copper Development Corporation. On October 5, 2015, the Company
changed its name from Copper Development Corporation to Life
Science Developments Limited, and on April 18, 2018, the Company
changed its name to Bradda Head Holdings Limited. On September 15,
2021, the Company changed its name to Bradda Head Lithium
Limited.
The Company has one business segment, being mineral exploration.
T he Company is focused on appraising and developing lithium mining
projects within North America and currently has interests in a
variety of projects in the United States.
Corporate and Exploration Highlights
Exploration Highlights
Set forth in this section is a description of the Company's
material mineral projects. All scientific and technical data
contained in this MD&A has been reviewed and approved by Joey
Wilkins, B.Sc., P.Geo., who is Head of North American Operations at
Bradda Head and a Qualified Person as defined by National
Instrument 43-101 - Standards of Disclosure for Mineral Projects
("NI 43-101").
Arizona Sedimentary Hosted Lithium Projects
Basin Project
Geological consultants, SRK Consulting (UK) ("SRK"), commenced
an updated Mineral Resource Estimate based on a 1,200m sonic drill
programme at Basin East ("BE"). This is planned as an interim
update whilst we prepare to drill at Basin East Extension ("BEE")
and Basin North ("BN"). The programme consisted of infill and
expansion drilling (14 holes total, 8 infill and 6 expansion). The
initial results from the programme showed that mineralization is
open to the north at BE, as well as the west and northwest as
previously identified.
Permitting efforts continued at Basin for permission to drill at
BEE and BN. Permission was awarded on May 2, 2022 to drill at BN,
with final permitting at BEE still in progress. Efforts now are
focused on ensuring that we access the areas with as little
disturbance as possible, with an expected drilling start date at BN
during Q1 2023.
Permitting is ongoing for the Plan of Operations permit at Basin
West ("BW") and Basin West Extension ("BWE"), and we expect a
decision on this in the second half of 2023. This is for an 80-hole
drill programme to test the resource potential at the c.11km(2)
area covered by BW and BWE.
Wikieup Project
Analysis is ongoing at Wikieup for a follow-up drill programme
in 2023, building on the initial sonic drill programme which
finished in early 2022.
Arizona Pegmatite District
San Domingo Project
Progress at the first diamond core scout programme at San
Domingo continued over the quarter, with good progress seen after
an initially mixed start due to adverse weather conditions over the
Arizona monsoon season. The Company has now moved assay labs to SGS
Canada Inc, following excessive delays (up to 17 weeks) from the
previous lab. As a result, assays are expected to be received in a
more consistent manner from now.
Visible lithium-bearing minerals were identified in the first
hole at this programme, including spodumene and lepidolite. To
confirm mineralogy, X-ray Diffraction ("XRD") was carried out on 8
samples from the intersections, identifying spodumene and
lepidolite in all holes.
The commencement of drilling followed positive results from a
recent SRK 3D mapping exercise, increasing potential pegmatite
outcrops by 190%. Following this, Bradda Head increased its staked
claims at San Domingo by 75% (press release dated 08 August 2022).
This first programme is expected to be finished in late
January/early February 2023, with final assays expected back before
the end of March 2023.
In late November, the Company released the results from a soil
sampling programme, covering c.11% of the San Domingo pegmatite
claims in Arizona. Results identified highly prospective follow-up
lithium targets over a 3km(2) + strike, with the same elemental
signatures that have been seen at known lithium mineralisation
locations globally. The soil geochemistry suggests that the
pegmatite swarm is largely of the lithium-caesium-tantalum (LTC)
mineralisation type, the most significant for lithium deposits and
what is commonly associated with economic occurrences of lithium
and tantalum. LCT-type pegmatites are found in the Western
Australian pegmatite district, like Tianqi and Albemarle's
joint-venture Greenbushes lithium mine.
Bradda Head carried out the soil sampling programme covering
just under 3km(2) of the northern claim block at San Domingo to
support future drill hole targeting and to better understand our
23km(2) pegmatite district in Arizona. Importantly, ratios present
in the soils of elements associated with pegmatites and lithium
mineralization highlight targets for potential follow-up. The maps
below show the areas of interest and, crucially, demonstrate a
9km(2) NE-SW trend, which may continue through the remainder of the
San Domingo 20km(2) of claims and state MEPs in Arizona, which have
not had detailed soil sampling.
Alongside the current drill programme, a follow-up field
observation, soil sampling, and channel sampling programme is now
underway across the full 23km(2) San Domingo pegmatite
district.
Nevada Lithium Brine Projects
Wilson Project
Planning is in place for an initial drill programme during the
first half of 2023, with the Company lining up a hydrogeological
specialist to review the project before drilling commences.
Eureka Project
Planning is in place for an initial drill programme during 2023,
and the Company lining up a hydrogeological specialist to review
the project before drilling commences
Corporate Highlights
On 13 April 2022, the Company announced the completion of a
successful fundraise. Aggregate gross proceeds of US$ 12,304,100
was raised, issuing 73,195,560 new ordinary shares, at a price of
GBP0.135 each. Investors who participated in the raised also
received one warrant for each ordinary shares, with an exercise
price of GBP0.21. The warrants expire two years after being
issued.
Issuance of Stock Options
On 20 April 2022, the Company announced that is awarded a total
of 9,200,000 options to acquire ordinary shares (the "Options") at
an exercise price of GBP0.18 to management and certain Board
members. Options for management and directors, are subject to the
following conditions:
- Options issued in three equal traches, with the initial tranche vesting immediately;
- Are exercisable for a period of five years from date of issue; and
- The options issued to each participant should lapse upon any
participant no longer being an employee or connected person
remunerated by the Company.
Directors included in the award are detailed in the table
below:
Director Total options Total shares Total diluted percentage
held at November held at November holding at November
30, 2022 30, 2022 30, 2022
Ian Stalker 17,250,000 3,870,140 5.40%
------------------ ------------------ -------------------------
Charles FitzRoy 10,000,000 13,265 2.56%
------------------ ------------------ -------------------------
Total 27,250,000 3,883,405 7.96%
------------------ ------------------ -------------------------
Selected Financial Information
The following table sets forth selected financial information
with respect to the Company for the years ended February 28, 2022,
and February 28, 2021. The selected financial information has been
derived from the audited financial statements for the periods
indicated. The following should be read in conjunction with the
said financial statements and related notes that are available on
the Company's website - www.braddaheadltd.com.
The annual financial statements and interim financial statements
are presented in US dollars and are prepared in accordance with
IFRS, See "Summary Financial Data" and "Currency Information".
Year ended February 28, 2022 Year ended February 28, 2021
(Audited) (Audited)
(US$) (US$)
----------------------------- -----------------------------
Statement of Operations:
----------------------------- -----------------------------
Total Revenue 2,413,228 -
----------------------------- -----------------------------
Total Operating Expenses (3,521,636) (633,188)
----------------------------- -----------------------------
Net Finance costs (32,832) (88,761)
----------------------------- -----------------------------
Net Loss (3,554,468) (721,949)
----------------------------- -----------------------------
Loss per Share (cents) (2.855) (0.011)
----------------------------- -----------------------------
Balance Sheet Data:
----------------------------- -----------------------------
Cash & cash equivalents 7,327,303 86,972
----------------------------- -----------------------------
Total Assets 13,354,840 2,649,118
----------------------------- -----------------------------
Total long-term Liabilities 1,097,675 1,547,208
----------------------------- -----------------------------
Total Liabilities 1,097,675 2,261,943
----------------------------- -----------------------------
Accumulated Deficit 11,177,220 9,056,687
----------------------------- -----------------------------
Total Shareholder's Equity 12,257,165 87,175
----------------------------- -----------------------------
MANAGEMENT DISCUSSION AND ANALYSIS: Q3 2022
Introduction
This interim Management Discussion and Analysis (the "interim
MD&A") should be read in conjunction with the unaudited
condensed interim financial statements of the Company for the three
and nine months ended November 30, 2022, and the audited financial
statements for the year ended February 28, 2022 and related notes.
This MD&A is made as of January 27, 2023.
Results of Operations for the nine-months ended November 30,
2022
The Company's net loss after tax for the nine-month period to
November 30, 2022 was US$ 3,074,862, compared to US$ 2,705,148 for
the comparative period ended November 30, 2021. The major expenses
for the three and nine-periods ended November 30, 2022 were
operational expenses incurred on the Company's exploration
projects, and are broken down in the respective projects as
follows:
Project Expensed Exploration Expenditure
Nine-Month Period ended November 30, 2022 Three-Month Period ended November 30, 2022
(Unaudited) (Unaudited)
US$ US$
------------------------------------------ -------------------------------------------
Basin Project 990,246 305,955
------------------------------------------ -------------------------------------------
Wikieup Project 84,905 10,633
------------------------------------------ -------------------------------------------
San Domingo Project 762,149 353,498
------------------------------------------ -------------------------------------------
Other projects 142,319 49,011
------------------------------------------ -------------------------------------------
TOTAL 1,979,620 719,097
------------------------------------------ -------------------------------------------
During this time period, the Company incurred and capitalised
exploration expenditures of US$ 1,728,158, compared to US$ 719,097
for the comparative nine-month period to November 30, 2021.
The capitalied exploration costs for the three and nine-periods
ended November 30, 2022 have been allocated amongst the Company's
exploration projects in approximately the following amounts:
Project Capitalisied exploration costs Capitalised expenditires for licences and
permits
Nine-Month Period Three-Month Period Nine-Month Period Three-Month Period
ended November 30, ended November 30, ended November 30, ended November 30,
2022 2022 2022 2022
(Unaudited) (Unaudited) (Unaudited) (Unaudited)
US$ US$ US$ US$
---------------------- ---------------------- ----------------------- ----------------------
Basin Project 230,659 19,200 70,365 6,834
---------------------- ---------------------- ----------------------- ----------------------
Wikieup Project * (207,387) 22,890 101,640 -
---------------------- ---------------------- ----------------------- ----------------------
San Domingo Project 1,574,278 1,410,725 81,165 9,660
---------------------- ---------------------- ----------------------- ----------------------
Other Project 130,609 - 453,122 -
---------------------- ---------------------- ----------------------- ----------------------
TOTAL 1,728,158 1,452,815 706,292 16,494
---------------------- ---------------------- ----------------------- ----------------------
* Note the negative amount for Wikieup is due to the transfer of
the drilling contractor deposit from deferred mining and
exploration costs to the Deposits Receivable balance sheet
account.
The exploration expenditures have been primarily costs
associated with drilling, assaying, resource and mining
consultants, metallurgical testing, environmental studies, project
team fees, acquisition of new leases, and annual renewal of
existing leases.
General and administrative expenses for the nine-month period to
Novemebr 30, 2022 totalled US$ 4,242,520 , compared to US$
1,690,543 for the comparative period to November 30, 2021. General
and administrative expenses are broken down as follows:
Project General and administrative expenditures
Nine-Month Period ended November 30, Three-Month Period ended November 30,
2022 2022
(Unaudited) (Unaudited)
US$ US$
-------------------------------------- --------------------------------------
Auditors' fees 114,508 13,067
-------------------------------------- --------------------------------------
Directors and management fees and
salaries 402,231 132,955
-------------------------------------- --------------------------------------
Legal and accounting 422,228 247,291
-------------------------------------- --------------------------------------
Contractor costs 1,979,619 719,097
-------------------------------------- --------------------------------------
Professional and marketing costs 942,495 332,928
-------------------------------------- --------------------------------------
Other administrative costs 381,439 245,205
-------------------------------------- --------------------------------------
TOTAL 4,242,520 1,690,543
-------------------------------------- --------------------------------------
During the nine-month periods to November 30, 2022 and November
30, 2021, there have been no changes in financial performance or
other elements that relate to non-core buisness activities and
operations.
Cash flows
During the nine-month period ended November 30, 2022, the
Company had net cash inflows of US$ 4,531,077, compared to inflows
of US$ 5,536,420 during the comparative nine-month period to
November 30, 2021. The cashflows for the two periods are shown
below:
Nine-Month Period ended November 30, Three-Month Period ended November 30,
2022 2022
(Unaudited) (Unaudited)
US$ US$
Statement of cashflows
-------------------------------------- --------------------------------------
Cash flows from operating activities (4,731,985) (989,785)
-------------------------------------- --------------------------------------
Cash flows from investing activities (2,493,122) (1,469,310)
-------------------------------------- --------------------------------------
Cash flows from financing activities 11,756,184 -
-------------------------------------- --------------------------------------
Net cash flows during the period 4,531,077 (2,459,095)
-------------------------------------- --------------------------------------
Cash balances at beginning of the
period 7,327,303 14,006,137
-------------------------------------- --------------------------------------
Effect of foreign exchange on cash
balances (1,255,343) (944,005)
-------------------------------------- --------------------------------------
Cash balances at the end of the
period 10,603,037 10,603,037
-------------------------------------- --------------------------------------
Liquidity and Capital Resources
As at November 30, 2022 the Company had cash and cash
equivalents of US$ 10,603,037, and a working capital surplus of US$
9,697,220. As of February 28, 2022, the Company had cash and cash
equivalents of US$ 7,327,303, and a working capital surplus of US$
6,327,624.
Outstanding Share Data
As of November 30, 2022, the following securities were
outstanding:
Shares 390,609,439
Warrants 81,698,305
------------
Stock options 32,360,304
------------
Fully diluted shares outstanding 504,668,048
------------
The Company's objectives when managing capital are to safeguard
its ability to continue as a going concern, so that it can continue
to provide returns for shareholders, benefits for other
stakeholders and to maintain an optimal capital structure to reduce
the cost of capital.
The capital structure of the Company includes cash and cash
equivalents, equity attributable to equity holders comprised of
contributed equity, reserves and accumulated losses. In order to
maintain or adjust the capital structure, the Company may issue new
shares, sell assets to reduce debt or adjust the level of
activities undertaken by the Company.
The Company monitors capital based on cash flow requirements for
operational, exploration and evaluation expenditures. The Company
has no debt or other borrowings as at the date of this Application.
The Company will continue to use capital market issuances to
satisfy anticipated funding requirements.
The availability of equity capital, and the price at which
additional equity could be issued, is dependent upon the success of
the Company's exploration activities, and upon the state of the
capital markets generally. Additional financing may not be
available on terms favourable to the Company or at all. If the
Company does not receive future financing, it may not be possible
for the Company to advance the exploration and development of its
mineral exploration properties. If the Company is not able to fund
these minimum expenditures, it may not be able to maintain part or
all of its mineral exploration property interests. See "Risk
Factors".
Off-Balance Sheet Arrangements
The Company does not have any off-balance sheet
arrangements.
Transactions with Related Parties
The Company has conducted transactions with officers, directors
and persons or companies related to directors or officers and paid
or accrued amounts as follows:
Edgewater Associates Limited ("Edgewater")
During the nine-month period ended November 30, 2022, Directors
and Officers insurance was obtained on an arms-length basis from
Edgewater, which is a 100% subsidiary of Manx Financial Group
("MFG"). James Mellon and Denham Eke are Directors of both the
Company and MFG.
During the period, the premium payable on the policy was US$
49,318 (year ended February 28, 2022: US$ 44,303), of which US$
32,122 was prepaid as at the period end (February 28, 2022: US$
11,076).
Critical Accounting Estimates
The preparation of financial statements in conformity with IFRS
requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial
statements and reported amounts of revenues and expenses during the
reporting period. Such estimates and assumptions affect the
carrying value of assets, and impact decisions as to when
exploration and development costs should be capitalized or
expensed.
As at November 30, 2022, the Company had incurred capitalised
exploration expenditures, including capitalised licence and permit
costs, of US$ 8,167,270. Changes in management's judgment as to the
prospective nature, assessment of the existence or otherwise of
economically recoverable reserves, technical feasibility and/or
commercial viability of the relevant tenements and the Company's
intentions with respect to the relevant tenements, could affect the
assessment of the recoverable amount.
The Company regularly reviews its estimates and assumptions:
however, actual results could differ from these estimates and these
differences could be material.
Condensed Interim Consolidated Statement of Comprehensive
Income
for the period ended November 30, 2022
Nine-month period Nine-month period Three-month period Three-month period
ended November 30, ended November 30, ended November 30, ended November 30,
2022 2021 2022 2021
(unaudited) (unaudited) (unaudited) (unaudited)
Notes US$ US$ US$ US$
Expenses
General and
administrative 2 (4,242,520) (2,391,522) (1,690,543) (764,201)
Share based payment
and warrant
expense 10 (1,285,743) (259,816) (91,539) (119,726)
Foreign exchange
loss (1,255,343) (34,338) (944,005) (4,197)
---------------- ---------------- ---------------- ----------------
Operating loss (6,783,606) (2,685,676) (2,726,087) (888,124)
Other income
Warrant fair value
re-measurement 11 3,711,264 - 880,920 -
Unrealised (loss) /
gain on investment (2,520) 13,360 - 5,461
---------------- ---------------- ---------------- ----------------
Loss before finance
costs (3,074,862) (2,672,316) (1,845,167) (882,663)
Finance costs - (32,832) - -
---------------- ---------------- ---------------- ----------------
Loss before income
tax (3,074,862) (2,705,148) (1,845,167) (882,663)
Income tax expense - - - -
---------------- ---------------- ---------------- ----------------
Loss for the period (3,074,862) (2,705,148) (1,845,167) (882,663)
Other comprehensive
income - foreign - 186 - -
currency
translation reserve
---------------- ---------------- ---------------- ----------------
Total comprehensive
loss for the
period (3,074,862) (2,704,962) (1,845,167) (882,663)
Basic and diluted
loss per share (US
cents) 12 (0.81) (1.50) (0.49) (0.49)
The accompanying notes are an integral part of these
consolidated interim financial statements.
Condensed Interim Consolidated Statement of Financial
Position
as at November 30, 2022
Notes November 30, 2022 February 28, 2022
(unaudited) (audited)
US$ US$
Non-Current assets
Deferred mining and exploration costs 3 5,911,902 4,183,744
Exploration permits and licences 4 2,255,368 1,549,076
Plant and equipment 8 89,134 54,170
Advances and deposits 6 507,906 88,594
Investment 51,436 53,957
-------------- --------------
Total non-current assets 8,815,746 5,929,541
-------------- --------------
Current assets
Cash and cash equivalents 10,603,037 7,327,303
Trade and other receivables 6 165,786 97,996
-------------- --------------
Total current assets 10,768,823 7,425,299
-------------- --------------
Total assets 19,584,569 13,354,840
Equity
Share premium 9 30,467,820 23,434,385
Retained deficit (12,966,339) (11,177,220)
-------------- --------------
Total equity 17,501,481 12,257,165
-------------- --------------
Current liabilities
Trade and other payables 7 1,071,603 1,097,675
Warrant liability 11 1,011,485 -
-------------- --------------
Total current liabilities 2,083,088 1,097,675
-------------- --------------
Total equity and liabilities 19,584,569 13,354,840
The accompanying notes are an integral part of these
consolidated interim financial statements.
These condensed interim consolidated financial statements were
approved by the Board of Directors on January 27, 2023 and were
signed on their behalf by:
Denham Eke
Director
Condensed Interim Consolidated Statement of Changes in
Equity
for the period ended November 30, 2022
Share premium Retained deficit Total
US$ US$ US$
Balance at March 1, 2022 (audited) 23,434,385 (11,177,220) 12,257,165
Total comprehensive loss for the period
Loss for the period - (3,074,862) (3,074,862)
------------ -------------- --------------
Total comprehensive loss for the period - (3,074,862) (3,074,862)
Transactions with owners of the Company
Issue of ordinary shares (note 9 and note 11) 7,581,351 - 7,581,351
Share issue costs capitalised (note 9) (547,916) - (547,916)
Equity settled share-based payments (note 10) - 1,285,743 1,285,743
------------ -------------- ------------
Total transactions with owners of the Company 7,033,435 1,285,743 8,319,178
------------ -------------- ------------
Balance at November 30, 2022 (unaudited) 30,467,820 (12,966,339) 17,501,481
The accompanying notes are an integral part of these
consolidated interim financial statements.
Condensed Interim Consolidated Statement of Changes in
Equity
for the period ended November 30, 2022 (continued)
Foreign currency
Share premium Retained deficit translation reserve Total
US$ US$ US$ US$
Balance at March 1, 2021
(audited) 9,443,676 (9,056,687) 186 387,175
Total comprehensive loss
for the period
Loss for the period - (2,705,148) - (2,705,148)
------------ -------------- -------------- --------------
Total comprehensive loss for the
period - (2,705,148) - (2,705,148)
Transactions with owners
of the Company
Issue of ordinary shares (note 8) 11,904,439 - - 11,904,439
Share issue costs capitalised
(note 8) (413,731) - - (413,731)
Equity settled share-based
payments (note 9) - 259,816 - 259,816
Transfer to retained deficit - 186 (186) -
------------ -------------- -------------- ------------
Total transactions with owners of
the Company 11,490,708 260,002 (186) 11,750,524
------------ -------------- -------------- ------------
Balance at November 30, 2021
(unaudited) 20,934,384 (11,501,833) - 9,432,551
The accompanying notes are an integral part of these
consolidated interim financial statements.
Condensed Interim Consolidated Statement of C ash Flows
for the period ended November 30, 2022
Nine-month Nine-month Three-month Three-month
period ended period ended period ended period ended
November 30, November 30, November 30, November 30,
2022 2021 2022 2021
Notes (unaudited) (unaudited) (unaudited) (unaudited)
US$ US$ US$ US$
Cash flows from operating activities
Loss before income tax (3,074,862) (2,705,148) (1,845,167) (882,663)
Adjusted for non-cash and
non-operating items:
Depreciation 8 23,708 - 9,532 -
Unrealised loss/(gain) on investment 2,520 (13,360) - (5,461)
Non-cash interest expense - 32,832 - -
Equity settled share based payments
expense 10, 11 1,285,743 259,816 91,539 119,726
Warrant fair value re-measurement 11 (3,711,264) - (880,920) -
Unrealised FX adjustment on - - - -
convertible loan note
Unrealised FX on cash balances 1,255,343 (34,338) 944,005 (4,197)
-------------- -------------- -------------- --------------
(4,218,812) (2,460,198) (1,681,011) (772,595)
Change in trade and other receivables (487,103) 51,470 (26,609) 255,140
Change in trade and other payables (26,070) 341,132 717,835 226,133
-------------- -------------- -------------- --------------
Net cash flows used by operating
activities (4,731,985) (2,067,596) (989,785) (291,322)
Cash flows from investing activities
Amounts paid for deferred mining and
exploration costs 3 (1,728,158) (1,121,721) (1,452,815) (964,459)
Amounts paid for licences and permits 4 (706,292) (519,455) (16,495) (112,018)
Equipment purchased 8 (58,672) - - -
-------------- -------------- -------------- --------------
Net cash flows used by investing
activities (2,493,122) (1,641,176) (1,469,310) (1,076,477)
Cash flows from financing activities
Short-term loan received - 60,000 - -
Cash received from shares and warrants
issued 9, 11 12,304,100 9,598,923 - -
Share issue costs paid 9 (547,916) (413,731) - -
-------------- -------------- -------------- --------------
Net cash flows from financing
activities 11,756,184 9,245,192 - -
-------------- -------------- -------------- --------------
Increase / (decrease) in cash and cash
equivalents 4,531,077 5,536,420 (2,459,095) (1,367,799)
Cash and cash equivalents at beginning
of period 7,327,303 86,972 14,006,137 7,021,332
Effect of foreign exchange on cash
balances (1,255,343) 34,338 (944,005) 4,197
-------------- -------------- -------------- --------------
Cash and cash equivalents at end
of period 10,603,037 5,657,730 10,603,037 5,657,730
The accompanying notes are an integral part of these
consolidated interim financial statements.
1 Reporting Entity and basis of preparation
Bradda Head Lithium Limited (the "Company") is a company
domiciled in the British Virgin Islands. The address of the
Company's registered office is Craigmuir Chambers, Road Town,
Tortola, British Virgin Islands. The Company and its subsidiaries
together are referred to as the "Group".
The Company is a lithium exploration Group focused on developing
its projects in the USA.
These interim financial statements have been prepared in
accordance with IAS 34 Interim Financial Reporting and should be
read in conjunction with the last annual consolidated financial
statements as at and for the year ended February 28, 2022 ("last
annual financial statements"). They do not include all of the
information required for a complete set of IFRS financial
statements. However, selected explanatory notes are included to
explain events and transactions that are significant to an
understanding of the changes in the Group's financial position and
performance since the last annual financial statements.
The financial information in this report has been prepared in
accordance with the Company's accounting policies and in
consistency with the last annual financial statements. Full details
of the accounting policies adopted by the Company are contained in
the financial statements included in the Company's annual report
for the year ended February 28, 2022, which is available on the
Group's website: www.braddheadltd.com , and on SEDAR at
www.sedar.com. These unaudited condensed consolidated interim
financial statements should be read in conjunction with the audited
Consolidated Financial Statements for the year ended February 28,
2022.
2 General and administrative
The Group's general and administrative expenses include the
following:
Nine-month period Nine-month period Three-month period Three-month period
ended November 30, ended November 30, ended November 30, ended November 30,
2022 2021 2022 2021
(unaudited) (unaudited) (unaudited) (unaudited)
US$ US$ US$ US$
Auditors' fees 114,508 62,067 13,067 35,466
Directors and
management fees and
salaries 402,231 310,653 132,955 120,942
Legal and accounting 422,228 510,218 247,291 83,665
Contractor costs 1,979,619 732,407 719,097 280,162
Professional and
marketing costs 942,495 535,899 332,928 203,672
Other administrative
costs 381,439 240,278 245,205 40,294
-------------- -------------- -------------- --------------
Total 4,242,520 2,391,522 1,690,543 764,201
3 Deferred mine exploration costs
The schedule below details the exploration costs capitalised to
date:
Total
US$
Cost and net book value
At February 28, 2021 (audited) 1,767,274
Capitalised during the year 2,501,853
Disposal under the royalty agreement (85,383)
--------------
At February 28, 2022 (audited) 4,183,744
--------------
Capitalised during the period 1,728,158
--------------
At November 30, 2022 (unaudited) 5,911,902
Cost and net book value
At November 30, 2022 (unaudited) 5,911,902
At February 28, 2022 (audited) 4,183,744
The recoverability of the carrying amounts of exploration and
evaluation assets is dependent on the successful development and
commercial exploitation or sale of the respective area of interest,
as well as maintaining the assets in good standing. The Group
assessed the DMEC relating to areas for which licenses and permits
are held, for impairment as at November 30, 2022. The Board
concluded that no facts and circumstances have been identified
which suggest the recoverable amount of these assets would not
exceed the carrying amount and, as such, no impairment was
recognised during the period.
During the year ended February 28, 2022, an impairment charge of
US$ Nil was recognised.
4 Exploration permits and licences
The schedule below details the exploration permit and licence
costs capitalised to date:
Total
US$
Cost and net book value
At February 28, 2021 (audited) 691,465
Capitalised during the year 1,119,455
Disposal under the royalty agreement (31,614)
Impairment (230,230)
--------------
At February 28, 2022 (audited) 1,549,076
Capitalised during the period 706,292
--------------
At November 30, 2022 (unaudited) 2,255,368
Cost and net book value
At November 30, 2022 (unaudited) 2,255,368
At February 28, 2022 (audited) 1,549,076
The Group assessed the carrying amount of the licences and
permits held for impairment as at November 30, 2022. The Board
concluded that no facts and circumstances have been identified
which suggest the recoverable amount of these assets would not
exceed the carrying amount and, as such, no impairment was
recognised during the period.
During the year ended February 28, 2022, an impairment charge of
US$ 230,230 was recognised as a result of project licences and
permits that were not renewed.
5 Investment in subsidiary undertakings
As at November 30, 2022 and February 28, 2022, the Group had the
following subsidiaries:
Name of company Place of Ownership Principal activity
incorporation interest
Bradda Head Limited* BVI 100% Holding company of entities
below
Zenolith (USA) LLC USA 100% Holds USA lithium licences
and permits
Verde Grande LLC USA 100% Holds USA lithium licences
and permits
Gray Wash LLC USA 100% Holds USA lithium licences
and permits
* Held directly by the Company. All other holdings are
indirectly held through Bradda Head Limited
The condensed interim consolidated financial statements include
the results of the subsidiaries for the full interim period from
March 1, 2022 to November 30, 2022, and up to the date that control
ceases.
6 Trade and other receivables and advances and deposits
Non-current
November 30, 2022 February 28, 2022
(unaudited) (audited)
US$ US$
Advances and deposits 507,906 88,594
Current
November 30, 2022 February 28, 2022
(unaudited) (audited)
US$ US$
Prepayments and other debtors 165,786 97,996
7 Trade and other payables
November 30, 2022 February 28, 2022
(unaudited) (audited)
US$ US$
Trade payables 950,402 1,019,175
Accrued expenses and other payables 121,201 78,500
------------ ------------
1,071,603 1,097,675
8 Plant and equipment
Motor vehicle Total
Cost US$ US$
As at March 1, 2021 (audited) - -
Additions during the year 55,718 55,718
------------ ------------
As at February 28, 2022 (audited) 55,718 55,718
Additions during the period 58,672 58,672
------------ ------------
As at November 30, 2022 (unaudited) 114,390 114,390
8 Plant and equipment (continued)
Motor vehicle Total
Accumulated depreciation US$ US$
As at March 1, 2021 (audited) - -
Depreciation charge for the year (1,548) (1,548)
------------ ------------
As at February 28, 2022 (audited) (1,548) (1,548)
Depreciation charge for the period (23,708) (23,708)
------------ ------------
As at November 30, 2022 (unaudited) (25,256) (25,256)
Carrying amount
As at November 30, 2022 (unaudited) 89,134 89,134
As at February 28, 2022 (audited) 54,170 54,170
9 Share premium
Authorised
The Company is authorised to issue an unlimited number of nil
par value shares of a single class.
Shares Share Share premium
capital
Issued ordinary shares of US$0.00 US$ US$
each
At February 28, 2021 (audited) 75,040,282 - 9,443,676
Shares issued for cash 158,499,941 - 12,098,924
Shares issued to settle loans 48,618,529 - 2,159,722
Shares issued in lieu of Directors
fees 3,037,362 - 145,794
Shares issued to Zenith Minerals
Limited * 32,217,765 -
Share issue costs capitalised - - (413,731)
-------------- -------------- --------------
At February 28, 2022 (audited) 317,413,879 - 23,434,385
Shares issued for cash (note 11) 73,195,560 - 7,581,351
Share issue costs capitalised - - (547,916)
-------------- -------------- --------------
At November 30, 2022 (unaudited) 390,609,439 - 30,467,820
* In line with the agreement entered into with Zenith Minerals
Limited ("Zenith"), shares were issued to Zenith to maintain
their shareholding at 15%. Following the listing of the Company's
shares on AIM in July 2021, the anti-dilution protection held
by Zenith no longer applies to any new issues of shares.
10 Equity settled share based payments
The cost of equity settled transactions with certain Directors
of the Company and other participants ("Participants") is measured
by reference to the fair value at the date on which they are
granted. The fair value is determined based on the Black-Scholes
option pricing model.
During the nine-month period ended November 30, 2022,
outstanding fees due to directors totaling US$ Nil were settled by
the issue of shares (28 February 2022: US$Nil)
Options and warrants
The total number of share options and warrants in issue as at
the period end is set out below.
Recipient Grant Term Exercise Number at Number Issued Number Lapsed/ Number Number at Fair value
Date in Price March 1, 2022 cancelled/expired Exercised November 30,
years (audited) 2022
(unaudited)
Options US$
Directors and
Participants April 2018 5 US$ 0.15668 1,606,304 - - - 1,606,304 24,028
Directors and
Participants June 2021 5 US$ 0.048 18,000,000 - - - 18,000,000 1,110,556
Directors and
Participants September 2021 5 GBP0.09 4,000,000 - - - 4,000,000 314,962
Directors and
Participants April 2022 5 GBP0.18 - 9,200,000 - - 9,200,000 1,122,876
Warrants
Supplier warrants July 2021 5 GBP0.0550 1,818,182 - - - 1,818,182 124,482
Supplier warrants July 2021 3 GBP0.0825 2,254,545 - - - 2,254,545 8,275
Shareholder December
warrants 2021 2 GBP0.0885 1,185,687 - - - 1,185,687 44,858
April
Supplier warrants 2022 2 GBP0.1350 - 3,244,331 - - 3,244,331 284,918
-------------- -------------- -------------- -------------- -------------- --------------
28,864,718 12,444,331 - - 41,309,049 3,034,955
10 Equity settled share based payments (continued)
The amount expensed in the income statement has been calculated
by reference to the fair value at the grant date of the equity
instrument and the estimated number of equity instruments to vest
after the vesting period.
Nine-month period Nine-month period Three-month period Three-month period
ended November 30, ended November 30, ended November 30, ended November 30,
2022 2021 2022 2021
(unaudited) (unaudited) (unaudited) (unaudited)
US$ US$ US$ US$
Share based payments
charge 1,285,743 259,816 91,539 -
The inputs used in the measurement of the fair values at grant
date of the equity-settled share-based payment plans issued during
the period are as follows:
April 2022 options
Award date and exercise price
Fair value at grant date GBP0.09308
Exercise price GBP0.180
Weight average expected volatility 81.90%
Weighted average expected life (years) 5
Risk-free interest rate (based on comparable companies) 1.52%
Terms of the issued options are as follows:
- 9,200,000 options have been granted and are subject to the
three independent vesting conditions for 1/3 of the entitlement,
relating to the successful fund raising in respect of the Group's
operational budget, commencement of a drilling program in respect
of the San Domingo project and resolution of certain Wickieup
project title claims. All un-exercised options expire after a
period of 5 years from grant date. It is assumed that options are
exercised within 5 years from date of grant. The applied volatility
is based on historical volatility.
April 2022 supplier warrants
Award date and exercise price
Fair value at grant date GBP0.06697
Exercise price GBP0.135
Weight average expected volatility 81.90%
Weighted average expected life (years) 2
Risk-free interest rate (based on comparable companies) 0.80%
Terms of the issued warrants are as follows:
- As part of the fundraise completed during April 2022, certain
service providers of the Company received warrants for services
rendered. As a result, 3,244,331 warrants have been issued. All
un-exercised warrants expire after a period of 2 years from grant
date. It is assumed that warrants are exercised within 2 years from
date of grant. The applied volatility is based on historical
volatility.
11 Warrants
The cost of equity warrants granted during the period are
measured by reference to the fair value at the date on which they
are granted. The fair value is determined based on the
Black-Scholes option pricing model.
During the nine-month period ended November 30, 2022, the
Company awarded warrants to investors who participated in the
fundraise completed during April 2022.
The total number of warrants in issue as at the period end is
set out below.
Recipient Grant Term Exercise Warrants at Number of Number of Number of Number of Fair value
Date in Price March 1, 2022 Warrants Warrants Lapsed/ Warrants Warrants at
years (audited) Issued cancelled/expired Exercised November 30,
2022
(unaudited)
Warrants US$
Shareholder April
warrants 2022 2 GBP0.2100 - 73,195,560 - - 73,195,560 1,011,485
-------------- -------------- -------------- -------------- -------------- --------------
- 73,195,560 - - 73,195,560 1,011,485
The fair value applied to the shareholder warrants has been
classified as a financial liability. At period end, the warrant
liability has been re-measured to fair value, with a corresponding
entry to profit and loss of US$ 3,711,264 (period ended November
30, 2021: Nil) within Warrant Fair Value Re-Measurement.
Reconciliation of warrant liability fair value:
Fair value
US$
Balance at March 1, 2022 -
Warrants issued during the period 4,722,749
Fair value re-measurement (3,711,264)
--------------
Balance at November 30, 2022 1,011,485
11 Warrants (continued)
April 2022 shareholder warrants
Grant date fair value Award date and exercise
price
Fair value at grant date GBP0.0492
Exercise price GBP0.21
Weight average expected volatility 81.90%
Weighted average expected life (years) 2
Risk-free interest rate (based on comparable
companies) 0.80%
November 30, 2022 fair value Award date and exercise
price
Fair value GBP0.0118
Exercise price GBP0.21
Weighted average expected volatility 80.5%
Weighted average expected life remaining
(years) 1.39
Risk-free interest rate (based on comparable
companies) 4.38%
As part of the fundraise completed during April 2022, all
participating shareholders received a warrant on 1:1 basis for
shares acquired. As a result, 73,195,560 warrants have been issued.
All un-exercised warrants expire after a period of 2 years from
grant date. It is assumed that warrants are exercised within 2
years from date of grant. The applied volatility is based on
historical volatility.
12 Basic and diluted loss per share
The calculation of basic profit per share of the Company is
based on the loss for the period of US$ 3,074,862 (nine-month
period to November 30, 2021: loss of US$ 2,052,489) and the
weighted average number of shares of 379,122,544 (at November 30,
2021: 147,618,936) in issue during the period.
Diluted loss per share is calculated by adjusting the weighted
average number of ordinary shares outstanding to assume conversion
of all dilutive potential ordinary shares such as warrants and
options. An adjustment for the dilutive effect of share options and
warrants in the current period has not been reflected in the
calculation of the diluted loss per share, as the effect would have
been anti-dilutive, due the Company recognising a loss for the
period.
13 Related party transactions and balances
Edgewater Associates Limited ("Edgewater")
During the nine-month period ended November 30, 2022, Directors'
and Officers' insurance was obtained on an arms-length basis
through Edgewater, which is a 100% subsidiary of Manx Financial
Group ("MFG"). James Mellon and Denham Eke are Directors of both
the Company and MFG.
During the period, the premium payable on the policy was US$
49,318 (year ended February 28, 2022: US$ 44,303), of which US$
32,122 was prepaid as at the period end (February 28, 2022: US$
11,076).
14 Commitments and contingent liabilities
The Group has certain obligations to expend minimum amounts on
exploration works on mining tenements in order to retain an
interest in them, equating to approximately US$ 415,454 during the
next 12 months. This includes annual fees in respect of licence
renewals. These obligations may be varied from time to time,
subject to approval and are expected to be filled in the normal
course of exploration and development activities of the
Company.
15 Events after the reporting date
On 21 December 2022, the Company awarded 500,000 ordinary share
options each to Euan Jenkins and Alex Borrelli, independent
non-executive directors of the Company.
ENDS
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
QRTEAPFXALADEEA
(END) Dow Jones Newswires
January 27, 2023 03:53 ET (08:53 GMT)
Bradda Head Lithium (LSE:BHL)
Historical Stock Chart
From Apr 2024 to May 2024
Bradda Head Lithium (LSE:BHL)
Historical Stock Chart
From May 2023 to May 2024